Monopar Therapeutics Inc. Common Stock is a biopharmaceutical company focused on developing targeted, antibody-based therapies for cancer treatment. With a strong pipeline of innovative drugs and a commitment to research and development, Monopar is poised to make a major impact in the field of oncology.